These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 10224339

  • 1. Mechanisms of action of quinolones against staphylococci and relationship with their in vitro bactericidal activity.
    Ramón MS, Cantón E, Pemán J, Pastor A, Martínez JP.
    Chemotherapy; 1999; 45(3):175-82. PubMed ID: 10224339
    [Abstract] [Full Text] [Related]

  • 2. In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
    Schumacher-Perdreau F, Peters G.
    Zentralbl Bakteriol; 1995 Oct; 282(4):389-93. PubMed ID: 9810661
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V, Messina C, Santagati M, Campanile F, Bonfiglio G, Stefani S.
    Drugs Exp Clin Res; 2001 Oct; 27(3):107-11. PubMed ID: 11447768
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Smith KR, Cobbs CG.
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activities of five quinolones against Chlamydia pneumoniae.
    Hammerschlag MR, Hyman CL, Roblin PM.
    Antimicrob Agents Chemother; 1992 Mar; 36(3):682-3. PubMed ID: 1320366
    [Abstract] [Full Text] [Related]

  • 7. Killing kinetics of four quinolones against gram-positive cocci.
    Cantón E, Ramon MS, Jimenez MT, Martinez JP.
    Chemotherapy; 1993 Mar; 39(6):394-9. PubMed ID: 8222866
    [Abstract] [Full Text] [Related]

  • 8. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
    Beskid G, Prosser BL.
    Am J Med; 1993 Mar 22; 94(3A):2S-8S. PubMed ID: 8383919
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).
    Cormican MG, Marshall SA, Jones RN.
    Diagn Microbiol Infect Dis; 1995 Jan 22; 21(1):51-4. PubMed ID: 7789097
    [Abstract] [Full Text] [Related]

  • 12. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
    Wallrauch C, Voss A, Milatovic D, Braveny I.
    Arzneimittelforschung; 1995 Jun 22; 45(6):723-5. PubMed ID: 7646580
    [Abstract] [Full Text] [Related]

  • 13. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
    Barry AL, Fuchs PC.
    J Antimicrob Chemother; 1991 Nov 22; 28(5):695-9. PubMed ID: 1663929
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
    Nishijima S, Nakagawa M, Tsuboi N, Akamatsu H, Horio T, Fujita M, Kawabata S.
    J Int Med Res; 1996 Nov 22; 24(1):12-6. PubMed ID: 8674789
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W.
    Chemotherapy; 1998 Nov 22; 44(2):77-84. PubMed ID: 9551236
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B, Navarro F, Miró E, Coll R, Xicota MA, Prats G.
    Drugs Exp Clin Res; 1995 Nov 22; 21(4):129-38. PubMed ID: 8529525
    [Abstract] [Full Text] [Related]

  • 20. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB, Swanson RN.
    Drugs Exp Clin Res; 1988 Nov 22; 14(6):375-8. PubMed ID: 3145851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.